Tweaking microtubules to treat scleroderma. by Jacob M van Laar, Tom W J Huizinga

Get full text

Autoimmune responses in the rheumatoid synovium. by Rene E M Toes, Tom W J Huizinga

Get full text

Substitution of the quantitative serological component in the 2010 criteria for RA with qualitative presence of three autoantibodies yields similar performance: response to the art... by Bastiaan T. van Dijk, Leendert A. Trouw, Annette H. M. van der Helm-van Mil, Tom W. J. Huizinga

Get full text

Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: A longitudinal cohort study in th... by Xanthe M E Matthijssen, Ellis Niemantsverdriet, Tom W J Huizinga, Annette H M van der Helm-van Mil

Get full text

Selective involvement of the amygdala in systemic lupus erythematosus. by Bart J Emmer, Jeroen van der Grond, Gerda M Steup-Beekman, Tom W J Huizinga, Mark A van Buchem

Get full text

Association between several clinical and radiological determinants with long-term clinical progression and good prognosis of lower limb osteoarthritis. by Erlangga Yusuf, Jessica Bijsterbosch, P Eline Slagboom, Herman M Kroon, Frits R Rosendaal, Tom W J Huizinga, Margreet Kloppenburg

Get full text

Handwork vs machine: a comparison of rheumatoid arthritis patient populations as identified from EHR free-text by diagnosis extraction through machine-learning or traditional crite... by T. D. Maarseveen, M. P. Maurits, E. Niemantsverdriet, A. H. M. van der Helm-van Mil, T. W. J. Huizinga, R. Knevel

Get full text

Pharmacological conditioning in the treatment of recent-onset rheumatoid arthritis: a randomized controlled trial study protocol by Meriem Manaï, Henriët van Middendorp, Dieuwke S. Veldhuijzen, Joy A. van der Pol, Tom W. J. Huizinga, Andrea W. M. Evers

Get full text

ACPA-negative RA consists of subgroups: patients with high likelihood of achieving sustained DMARD-free remission can be identified by serological markers at disease presentation by Debbie M. Boeters, Leonie E. Burgers, Eric H. Sasso, Tom W. J. Huizinga, Annette H. M. van der Helm – van Mil

Get full text

Does treatment strategy influence the ability to achieve and sustain DMARD-free remission in patients with RA? Results of an observational study comparing an intensified DAS-steere... by L. E. Burgers, J. A. van der Pol, T. W. J. Huizinga, C. F. Allaart, A. H. M. van der Helm-van Mil

Get full text

Similar short-term clinical response to high-dose versus low-dose methotrexate in monotherapy and combination therapy in patients with rheumatoid arthritis by Sytske Anne Bergstra, Cornelia F. Allaart, Rosaline van den Berg, Arvind Chopra, Nimmisha Govind, Tom W. J. Huizinga, Robert B. M. Landewe

Get full text

Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with collagen induced arthritis. by Jeroen N Stoop, Bi-Sheng Liu, Jing Shi, Diahann T S L Jansen, Martin Hegen, Tom W J Huizinga, Leendert A Trouw, René E M Toes

Get full text

Can Pharmacological Conditioning as an Add-On Treatment Optimize Standard Pharmacological Treatment in Patients with Recent-Onset Rheumatoid Arthritis? A Proof-of-Principle Randomi... by Meriem Manaï, Henriët van Middendorp, Joy A. van der Pol, Cornelia F. Allaart, Elise Dusseldorp, Dieuwke S. Veldhuijzen, Tom W. J. Huizinga, Andrea W. M. Evers

Get full text

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations by Margreet Kloppenburg, Tom W J Huizinga, Leendert A Trouw, Gerda M Steup-Beekman, Rory C Monahan, Michelle D van den Beukel, Nicole V Borggreven, Rolf Fronczek

Get full text

Evolution of anti-modified protein antibody responses can be driven by consecutive exposure to different post-translational modifications by M. Volkov, A. S. B. Kampstra, K. A. van Schie, A. Kawakami, M. Tamai, S. Kawashiri, T. Maeda, T. W. J. Huizinga, R. E. M. Toes, D. van der Woude

Get full text

Repair of joint damage in patients with rheumatoid arthritis does not relate to previous suppression of inflammation: a subanalysis after 8 years treat-to-target in the BeSt-trial by Cornelia F Allaart, Tom W J Huizinga, Linda Dirven, Willem F Lems, Pit J S M Kerstens, Marianne van den Broek, Gülşah Akdemir, Iris M Markusse, Joy Ardjuna van der Pol

Get full text

Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies by Cornelia F Allaart, Tom W J Huizinga, René E M Toes, Hans Ulrich Scherer, Jeska K de Vries-Bouwstra, Sophie I E Liem, Sam Neppelenbroek, Cynthia M Fehres, Brigitte A Wevers

Get full text

Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations by Emma C. de Moel, Leendert A. Trouw, Chikashi Terao, Nimmisha Govind, Mohammed Tikly, Hani El-Gabalawy, Irene Smolik, Holger Bang, Tom W. J. Huizinga, René E. M. Toes, Diane van der Woude

Get full text

A Polymorphism in C-C Chemokine Receptor 5 (CCR5) Associates with Löfgren’s Syndrome and Alters Receptor Expression as well as Functional Response by Bekir Karakaya, Coline H. M. van Moorsel, Marcel Veltkamp, Claudia Roodenburg-Benschop, Karin M. Kazemier, Annette H. M. van der Helm-van Mil, Tom W. J. Huizinga, Jan C. Grutters, Ger T. Rijkers

Get full text

Anti-carbamylated protein antibodies in systemic sclerosis by Sophie I. E. Liem, E. M. Hoekstra, E. W. Nivine Levarht, Annemarie L. Dorjee, Hans U. Scherer, René E. M. Toes, Tom W. J. Huizinga, Jeska K. de Vries-Bouwstra, Cynthia M. Fehres

Get full text